APO FLUPHENAZINE TAB 2.5MG 2.5 MG
FLUPHENAZINE HYDROCHLORIDE : 2.5 MG · DIN 00405353 · APOTEX INC
Health Canada status: CANCELLED POST MARKET
What is APO FLUPHENAZINE TAB 2.5MG?
APO FLUPHENAZINE TAB 2.5MG 2.5 MG contains FLUPHENAZINE HYDROCHLORIDE : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00405353, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 29-May-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00405353 |
|---|---|
| Brand name | APO FLUPHENAZINE TAB 2.5MG |
| Generic / active ingredient | FLUPHENAZINE HYDROCHLORIDE : 2.5 MG |
| Manufacturer | APOTEX INC |
| Strength | 2.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AB02 FLUPHENAZINE |
| AHFS class | 28:16.08.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-May-2019 |
| Original market date | 1977-12-31 00:00:00 |
Is FLUPHENAZINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N05AB02 FLUPHENAZINE. 3 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUPHENAZINE | 1 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00405345 |
| FLUPHENAZINE | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00410632 |
| FLUPHENAZINE | 5 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00405361 |
| APO-FLUPHENAZINE INJECTABLE | 25 MG | LIQUID | APOTEX INC | CANCELLED POST MARKET | DIN 02244166 |
| FLUPHENAZINE 1 TAB 1MG | 1 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563846 |
| FLUPHENAZINE 2 TAB 2MG | 2 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563838 |
| FLUPHENAZINE 5 TAB 5MG | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563803 |
| FLUPHENAZINE DECANOATE INJECTION B.P. | 100 MG | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED PRE MARKET | DIN 02189097 |
| FLUPHENAZINE DECANOATE INJECTION B.P. | 25 MG | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED PRE MARKET | DIN 02189089 |
| FLUPHENAZINE DECANOATE INJECTION, USP | 25 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | DIN 02383225 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.